Neoadjuvant Therapy with Immune Checkpoint Blockade, Antiangiogenesis, and Chemotherapy for Locally Advanced Gastric Cancer

In this single-armed, phase II, exploratory trial, researchers evaluated the efficacy of a combination of immune checkpoint inhibitors, antiangiogenesis, and chemotherapy for neoadjuvant/conversion treatment of cT4a/bN+ gastric cancer.